Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter

This publication has 32 references indexed in Scilit:

• Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
  Oncogene, 2001
• Par4 is a coactivator for a splice isoform–specific transcriptional activation domain in WT1
  Genes & Development, 2001
• A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma Cells
  Published by Elsevier ,2000
• Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis
  Oncogene, 1999
• Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4
  Oncogene, 1999
• The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t(14;18) Lymphomas
  Journal of Biological Chemistry, 1997
• A License to Kill
  Cell, 1996
• Liarozole amplifies retinoid-induced apoptosis in human prostate cancer cells
  Anti-Cancer Drugs, 1996
• bcl-2 Protein in Non-Small-Cell Lung Carcinoma
  New England Journal of Medicine, 1993
• Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
  Science, 1984